Introduction
The clinical features of sickle-cell disease have been recognized for many years, the disease being described by Herrick (1910) , later Sydenstricker (1924) reported on a large series of cases. In 1931, Yater & Mollari described a case with fatal outcome; Kobak, Stein & Daro (1941) made a detailed study of pregnancy in association with sickle-cell disease. The demonstration by Pauling et al. (1949) of an abnormal haemoglobin in the erythrocytes of patients with the disease led rapidly to the identification of additional haemoglobin variants and the introduction of filter-paper electrophoresis by Spaet (1953) allowed of identification of abnormal haemoglobins in general hospital practice, so allowing separation of cases which may previously have been included as sickle-cell disease but which were, in fact, cases of sickle-cell/haemoglobin C disease or cases of sickle-cell/thalassaemia.
An increasing number of papers has since appeared dealing with the problem in the pregnant woman (Adams, Whitacre & Diggs, 1953; Eisenstein, Posner & Friedman, 1956 ; Curtis, 1959; Abrams & Schwartz, 1959; Anderson et al., 1960 ). These papers have described cases occurring in the United States of America and the West Indies and to date there has been little information concerning cases in the United Kingdom (Reiss, 1962; Apthorp, Measday & Lehmann, 1963) . Routine ante-natal haemoglobin electrophoresis screening of negro women has been reported from the United States of America (Curtis, 1959; Cotter & Prystowsky, 1963) , from the West Indies (Anderson et al., 1960) and from the United Kingdom (Buckle, Hanning & Holman, 1964) . The results obtained from such screening show a comparable incidence of cases of sicklecell disease, sickle-cell/haemoglobin C disease and sickle-cell/thalassaemia, an incidence of 0 18% for these three conditions being reported by Buckle et al. (1964) In general, in sickle-cell disease, there will be chronic anaemia, jaundice, weakness, fatigue, bone and joint pain, and abdominal pain. Signs include fever, bone tenderness, occasional splenomegaly, hepatomegaly, underdevelopment and malnutrition. Symptoms date from early childhood and the condition may well have been diagnosed before pregnancy. The same is not necessarily true of sickle-cell/haemoglobin C disease or of sickle-cell/thalassaemia and routine screening of patients likely to be affected is desirable.
Effects of pregnancy on sickle-cell diseases
There have been conflicting reports on the seriousness of pregnancy occurring in patients with the sickle-cell diseases. Smith & Conley (1954) suggested that pregnancy was more hazardous in patients with sickle-cell /haemoglobin C disease, a view which received support from papers by Edington (1957) and Molina & Marks (1957) . Eisenstein et al. (1956) reported a postpartum maternal death in a patient with sicklecell disease. Curtis (1959) 8-2 and 9-3 g/ 100 ml. Spontaneous onset of labour at 38 weeks was followed by normal vaginal delivery of a live male infant, weight 2-6 kg. The puerperium was uneventful and alkali was discontinued at the time of discharge from hospital (this patient was admitted 9 months later under the care of the physicians with a crisis and pulmonary infarct got out of bed, fell to the floor, lost consciousness and died within a few minutes. Post-mortem examination of the blood confirmed the patient as being of genotype SS, death resulting from bone marrow infarction with pulmonary, fat embolism.
Case 5 (Hospital No. D 39069)
A 21-year-old Gambian, gravida 4. Genotype SS. There was no relevant medical history. The three previous pregnancies (elsewhere) had been uneventful. In the fourth pregnancy (at this hospital), the patient attended for ante-natal booking at 14 weeks' gestation. There was no hepatomegaly but the spleen was enlarged and there were old scars on the legs. The haemoglobin level was 10 6 g/ 100 ml. She was commenced on oral alkali and supplementary folic acid and remained well throughout pregnancy apart from one attack of fleeting joint pain at 34 weeks' gestation, hospital admission not being necessary. Labour commenced spontaneously at 38 weeks' gestation, the patient delivering herself of a live male infant, weighing 3-2 kg. The puerperium was uneventful and alkali treatment was discontinued at the time of discharge from hospital.
Case 6 (Hospital No. D 8141)
An 18-year-old Jamaican, gravida 1. Genotype The patient attended for ante-natal booking at 16 weeks' gestation. There was no hepatomegaly, but the spleen was enlarged and there were old scars on the legs. The haemoglobin at booking was 8-6g/100ml. She was commenced on alkali and supplementary folic acid and the haemoglobin varied between 7-8 and 9.9g/100ml during pregnancy; there were no crises. Labour commenced spontaneously at 38 weeks and the patient delivered herself of a live female infant, weight 2-6 kg. The puerperium was uneventful, free from crisis and the haemoglobin after delivery was 10-5 g/ 100 ml.
This patient re-attended for ante-natal booking 18 months later. A similar regimen was instituted and pregnancy was uneventful. She went into labour spontaneously at 37 weeks and delivered a live male infant weighing 2-3 kg. The puerperium was uneventful, tubal ligation being carried out on the 5th post-partum day under general anaesthesia.
Case 8 (Hospital No. B 22357)
A 23-year-old gravida 2 from Granada. Genotype S/Thalassaemia. There was no relevant medical history and the previous pregnancy had ended in a spontaneous abortion at 10 weeks. In the current pregnancy, the patient attended for ante-natal booking at 14 weeks. There was no splenomegaly and no hepatomegaly and the haemoglobin level was 10 5 g/ 100 ml. Pregnancy was entirely uneventful and labour commenced spontaneously at 39 weeks' gestation, a live female infant weighing 3 0 kg being delivered. The puerperium was uncomplicated.
In her second observed pregnancy 5 years later, the pregnancy was again entirely uneventful and vaginal delivery of a living female infant weighing 3-3 kg took place at 39 weeks' gestation.
There was no anaemia during pregnancy and the puerperium was uncomplicated. Case 9 (Hospital No. B 54658)
A 30-year-old gravida 2 from Jamaica. Genotype S/Thalassaemia. There was a long-standing history of jaundice and investigation under the care of the physicians had revealed her abnormal haemoglobin state. In her first pregnancy (elsewhere), there had apparently been no abnormality.
In her second pregnancy, at this hospital, the patient attended ante-natal booking at 24 weeks' gestation. There was no hepatomegaly but the spleen was palpable. The haemoglobin was 9 g/ 100 ml. There was a persistent anaemia throughout pregnancy, which was otherwise uneventful. The patient commenced labour spontaneously at 39 weeks and delivered herself of a live female infant, weight 4-0 kg. The puerperium was uneventful.
Patient management during pregnancy
The patients have been seen at frequent intervals during the ante-natal period and carefully observed, particularly from the haematological point of view, blood examination being carried out at each attendance. An adequate diet, with special regard to a good protein intake, has been advised but, in so far as these patients generally have adequate iron stores (Monitt, 1963) , oral iron only was given during pregnancy and no recourse was had to parenteral iron. Serum iron levels have been estimated (see Table 3 ).
As crises may result from a rise in temperature, the patients have been warned to report any illness and have, where necessary, been given anti-biotic cover for such illnesses. In addition, routine screening of the urine has been carried out during pregnancy to exclude chronic pyelonephritis, for patients with sickle-cell/haemoglobin C disease have been reported as having this condition more frequently than other patients (McCurdy, 1964) . Stool examination has also been routinely carried out (Table 3) .
The continuing demand on the haemotopoietic function of the bone marrow means that supplementary folic acid should be supplied and this is particularly the case during pregnancy, where there is the additional demand from the foetus. A daily dose of 5 mg of folic acid has therefore been given throughout pregnancy.
As mentioned earlier in this paper, sickling occurs with falling oxygen tension and is favoured by a lowering of the pH or a rise in the body temperature. Greenberg & Kass (1958) drew attention to the effect of acidosis on sickling and Lehmann (1963) pointed out that, without local acidosis, stasis or firm intravascular wedging of the sickled blood, infarctive crises do not occur. He felt that alkali treatment played its part in the prevention of sickling rather than in the treatment of the crisis. Stasis encourages sickling because the cell loses oxygen and there is a rise of acid metabolites, but the greater the alkali reserve, the longer stasis would have to last to result in sickling. Lehmann further pointed out that, for a painful and lasting crisis, the cells have to be bound together by clotting plasma. Intravenous magnesium sulphate may delay the increase in viscosity and also, if clotting has taken place, prevent further strengthening of the clot, so allowing gradual reduction in its size. On this basis he advocated a regimen of intravenous magnesium sulphate during crisis, followed by oral magnesium and this to be followed by a regimen of oral sodium bicarbonate.
Our patients have been kept on oral sodium bicarbonate throughout pregnancy, sufficient being given to keep all urine specimens alkaline. The patients have been instructed to test every specimen with litmus paper and it has been possible to obtain full co-operation on this point. The average amount of sodium bicarbonate given has been 2 g 6-hourly during the day and 4 g at night. During crises, the patients have been admitted and alkali treatment, possibly in increased amount, continued and intravenous magnesium sulphate given as outlined above.
Blood transfusion has been avoided whenever possible; although available at the time of operation, it has only been necessary to transfuse one patient. It was reported by Went & McIver (1958) that when transfusion took place, there was a diminished reticulocytosis which returned to usual levels when the haemoglobin had returned to the pre-transfusion level.
Management at the time of delivery Where vaginal delivery has been anticipated, labour, if not commencing spontaneously, has been induced at or shortly before term in order to avoid the additional placental hypoxia which may occur in post-term delivery. After the spontaneous or induced commencement of labour, intravenous dextrose-saline has been commenced, oral alkali continued and intravenous magnesium sulphate given 6-hourly in a dose of 2 ml of a 50% solution, the regimen continuing throughout labour and for the first 24 hr of the post-partum period, after which time the patient has returned to the oral alkali regimen. If any urine specimen during labour has been of acid reaction, intravenous sodium bicarbonate has been substituted for the oral alkali.
In those cases where elective Caesarian section has been advisable because of the difficulty of induction of labour, an identical routine has been employed. Anaesthesia has been standard thiopentone-scoline-gas-oxygen-pethidine, great care being taken to avoid hypoxia. It has been thought advisable to give prophylactic antibiotic to any patient delivered in this way.
Management in the puerperium
The oral alkali and supplementary folic acid have been continued after delivery until the time of discharge from hospital. The question of continuation beyond this time has not been thought necessary and in many instances not possible as the patients have been difficult to contact. Blood has been taken from the father of the child in order to give some idea of the likely genotype of the child. Contraceptive advice has been given to these, as to all other patients in the unit, but in view of problems in ensuring that oral contraception is taken correctly, intrauterine devices have been preferred. In selected cases, post-partum tubal ligation has been carried out.
Discussion
Symptoms in sickle-cell disease commence in early childhood and the natural history of the condition is of chronic ill-health with haemolytic anaemia, painful or haemolytic crises interrupting the condition from time to time. In sicklecell/haemoglobin C disease, symptoms may be manifest for the first time during pregnancy or as a result of infection. The deleterious aspects of the conditions are two-fold, namely the haemo-lytic anaemia and the crises. As Lehmann (1963) pointed out, the former is no more severe than in other congenital or acquired haemolytic anaemias and required protection from infection and supplementary folic acid to maintain haemotopoiesis. The infarctive crises, resulting from deoxygenation of the abnormal cells, are favoured by local acidosis, vascular stasis and intravascular wedging of the sickled cells. After Greenberg & Kass (1958) had drawn attention to the role of acidosis in sickling crises, an alkali regimen was used in treatment (Scott & Ferguson, 1960) . The additional use of magnesium with the object of preventing the conversion of partially sickled and sludged cells into a firm plug was advocated (Anstall et al., 1959; Huntsman, Hurn & Lehmann, 1960 ) but it was later reported (Apthorp et al., 1963 ) that alkali treatment alone was equally effective in the prevention of infarctive episodes, although the latter authors gave intravenous magnesium in the early stages of acute episodes or during operation.
As mentioned earlier in this paper, reports are conflicting on the seriousness of the association of the sickle-cell disease and pregnancy and it is not possible to draw any conclusions from the cases in the present series because of the small number involved. Further reports will be required before firm comment can be made. The impression gained from questioning the patients has been that, although not symptom-free on the regimen outlined, they have been very much less troubled during and after delivery when so managed than when not on alkali treatment. The one maternal death occurred in a patient who had not been managed by the alkali regimen and who died from pulmonary fat embolism shortly after delivery. As this occurs independently of pregnancy, it is not possible to know whether the patient would not have succumbed even if she had been on treatment. The one stillbirth in the series occurred in a patient who went into premature labour after possible pulmonary infarction and the foetal heart ceased shortly before delivery. Later pregnancy in the same patient has been successful.
